Protein Deficiency Seen in Neurons Born in Adulthood and Those Affected by Disease

Join Our Community of Science Lovers!


On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.


Scientists have found a link between neurons generated during adulthood and those that fall victim to diseases such as Alzheimer's. According to a new report, both types of brain cells have strangely low levels of a protein known as UCHL1.

The discovery that new neurons can arise in adult brains--a feat first observed in songbirds--overturned the long-held belief that a vertebrate's complete supply of neurons is created at birth or soon thereafter. In the new work, Fernando Nottebohm of Rockefeller University and his colleagues investigated how latecomer neurons differ from lifelong ones. The researchers injected two types of dye into the brains of 19 songbirds and collected samples from both types of neurons, which are used in two different pathways in the brain. After analyzing genetic information from more than 3,000 cells from each animal, the team determined that one gene (UCHL1) showed remarkably low activity in the newer, or "replaceable neurons": the longstanding ones exhibited 2.5 times the amount of the UCHL1 protein. "Low levels of UCHL1 appear to be a feature of replaceable neurons wherever they occur," says study co-author Anthony Lombardino of Rockefeller University.

Work with mice confirmed the correlation between low levels of UCHL1 and replaceable neurons. Finally, the scientists investigated whether levels of UCHL1 change when the animals sing--an activity that had previously been shown to increase the odds of survival for newly generated neurons. After the male birds sang to a female, the levels of UCHL1 in their replaceable neurons had increased. "These findings suggest that rising levels of UCHL1 may be associated with a reduced risk of neuronal death," Nottebohm explains. The results, published online this week by the Proceedings of the National Academy of Sciences, complement other studies that had linked deficiencies in UCHL1 to degenerative diseases such as Alzheimer's and Parkinson's disease.

It’s Time to Stand Up for Science

If you enjoyed this article, I’d like to ask for your support. Scientific American has served as an advocate for science and industry for 180 years, and right now may be the most critical moment in that two-century history.

I’ve been a Scientific American subscriber since I was 12 years old, and it helped shape the way I look at the world. SciAm always educates and delights me, and inspires a sense of awe for our vast, beautiful universe. I hope it does that for you, too.

If you subscribe to Scientific American, you help ensure that our coverage is centered on meaningful research and discovery; that we have the resources to report on the decisions that threaten labs across the U.S.; and that we support both budding and working scientists at a time when the value of science itself too often goes unrecognized.

In return, you get essential news, captivating podcasts, brilliant infographics, can't-miss newsletters, must-watch videos, challenging games, and the science world's best writing and reporting. You can even gift someone a subscription.

There has never been a more important time for us to stand up and show why science matters. I hope you’ll support us in that mission.

Thank you,

David M. Ewalt, Editor in Chief, Scientific American

Subscribe